Global Conjugate Vaccine Market:
The global market for conjugate vaccines will expand at a CAGR of 14.6% to reach a value of USD 100.59 Bn by 2023. Increased adoption of therapeutic vaccines for cancer, improved patient compliance, a larger product pipeline, and efforts to promote adoption of screening methods are some of the factors that will lead to the growth of the market. The Asia-Pacific market will exhibit the highest growth rate.
The vaccines are classified based on the diseases that they are target at - such as pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal, and others - and on the end users, into pediatric and adults. Technological advancements and regular vaccination programs by authorities are some of the factors that will help overcome the challenges posed by lack of awareness, shortages, uncertainty about future initiatives, and costs. Companies like GlaxoSmithKline, Pfizer Inc., Sanofi Pasteur, and Novartis are some of the major players operating in the market.
The subsequent information conveyed will be on an Excel sheet, presented in an easily identifiable format.
List of Figures/Charts
Chapter 2:
1. Global historical (2015-2017) market revenue (USD Bn)
2. Global forecasted (2018-2023) market revenue (USD Bn)
3. Geography-wise (2018-2023) market revenue (USD Bn)
4. Global historical (2015-2017) market volume (Million units)
5. Global forecasted (2018-2023) market volume (Million units)
6. Geography-wise (2018-2023) market volume (Million units)
7. North America historical (2015-2017) market revenue (USD Bn)
8. North America forecasted (2018-2023) market revenue (USD Bn)
9. North America historical (2015-2017) market volume (Million units)
10. North America forecasted (2018-2023) market volume (Million units)
11. Europe historical (2015-2017) market revenue (USD Bn)
12. Europe forecasted (2018-2023) market revenue (USD Bn)
13. Europe historical (2015-2017) market volume (Million units)
14. Europe forecasted (2018-2023) market volume (Million units)
15. APAC historical (2015-2017) market revenue (USD Bn)
16. APAC forecasted (2018-2023) market revenue (USD Bn)
17. APAC historical (2015-2017) market volume (Million units)
18. APAC forecasted (2018-2023) market volume (Million units)
19. LATAM historical (2015-2017) market revenue (USD Bn)
20. LATAM forecasted (2018-2023) market revenue (USD Bn)
21. LATAM historical (2015-2017) market volume (Million units)
22. LATAM forecasted (2018-2023) market volume (Million units)
23. MEA historical (2015-2017) market revenue (USD Bn)
24. MEA forecasted (2018-2023) market revenue (USD Bn)
25. MEA historical (2015-2017) market volume (Million units)
26. MEA forecasted (2018-2023) market volume (Million units)
27. Value chain
Chapter 3:
1. Pneumococcal - (2015, 2018, 2023) global revenue(USD Bn)
2. Pneumococcal - (2015, 2018, 2023) global volume (Million units)
3. Hib - (2015, 2018, 2023) global revenue(USD Bn)
4. Hib - (2015, 2018, 2023) global volume (Million units)
5. DTP - (2015, 2018, 2023) global revenue(USD Bn)
6. DTP - (2015, 2018, 2023) global volume (Million units)
7. Meningococcal - (2015, 2018, 2023) global revenue(USD Bn)
8. Meningococcal - (2015, 2018, 2023) global volume (Million units)
Chapter 4:
1. Paediatric - (2015, 2018, 2023) global revenue(USD Bn)
2. Paediatric - (2015, 2018, 2023) global volume(Million units)
3. Adult - (2015, 2018, 2023) global revenue(USD Bn)
4. Adult - (2015, 2018, 2023) global revenue(Million units)
Chapter 5, 7, 9, 11, 13:
1. Pneumococcal conjugate vaccine market -(2015, 2018, 2023) by revenue (USD Bn)
2. Pneumococcal conjugate vaccine market -(2015, 2018, 2023) by volume (Million units)
3. Haemophilus Influenza Type b conjugate vaccine market -(2015, 2018, 2023) by revenue (USD Bn)
4. Haemophilus Influenza Type b conjugate vaccine market -(2015, 2018, 2023) by volume (Million units)
5. Diphtheria-Tetanus-Pertussis conjugate vaccine market -(2015, 2018, 2023) by revenue (USD Bn)
6. Diphtheria-Tetanus-Pertussis conjugate vaccine market -(2015, 2018, 2023) by volume (Million units)
7. Meningococcal conjugate vaccine market -(2015, 2018, 2023) by revenue (USD Bn)
8. Meningococcal conjugate vaccine market -(2015, 2018, 2023) by volume (Million units)
Chapter 6, 8, 10, 12, 14:
1. Pediatric vaccine market -(2015, 2018, 2023) by revenue (USD Bn)
2. Pediatric vaccine market -(2015, 2018, 2023) by volume (Million units)
3. Adult vaccine market -(2015, 2018, 2023) by revenue (USD Bn)
4. Adult vaccine market -(2015, 2018, 2023) by volume (Million units)
Chapter 15:
1. Top 5 companies
List of Tables:
Table 1: Global segment by disease indication (2015 - 2023) value in USD Bn
Table 2: Global segment by disease indication (2015 - 2023) volume in Million units
Table 3: Global segment by end user (2015 - 2023) value in USD Bn
Table 4: Global segment by end user (2015 - 2023) value in Million units
Table 5: Segment by geography (2015 - 2023) value in USD Bn
Table 6: Segment by geography (2015 - 2023) volume in Million units
Table 7: North America - segment by disease indication (2015 - 2023) value in USD Bn
Table 8: North America - segment by end user (2015 - 2023) value in USD Bn
Table 9: North America - segment by disease indication (2015 - 2023) volume in Million units
Table 10: North America - segment by end user (2015 - 2023) volume in Million units
Table 11: Europe - segment by disease indication (2015 - 2023) value in USD Bn
Table 12: Europe - segment by end user (2015 - 2023) value in USD Bn
Table 13: Europe - segment by disease indication (2015 - 2023) volume in Million units
Table 14: Europe - segment by end user (2015 - 2023) volume in Million units
Table 15: APAC - segment by disease indication (2015 - 2023) value in USD Bn
Table 16: APAC - segment by end user (2015 - 2023) value in USD Bn
Table 17: APAC - segment by disease indication (2015 - 2023) volume in Million units
Table 18: APAC - segment by end user (2015 - 2023) volume in Million units
Table 19: LATAM - segment by disease indication (2015 - 2023) value in USD Bn
Table 20: LATAM - segment by end user (2015 - 2023) value in USD Bn
Table 21: LATAM - segment by disease indication (2015 - 2023) volume in Million units
Table 22: LATAM - segment by end user (2015 - 2023) volume in Million units
Table 23: MEA - segment by disease indication (2015 - 2023) value in USD Bn
Table 24: MEA - segment by end user (2015 - 2023) value in USD Bn
Table 25: MEA - segment by disease indication (2015 - 2023) volume in Million units
Table 26: MEA - segment by end user (2015 - 2023) volume in Million units
Table 27: Population aged 80 years or over for the world, regions and income groups, 2000, 2015, 2030 And 2050
Table 28: Percentage of the population of older age group (aged 65 and above) by country: 1950, 1980, 2015, and 2050 (Est.)
Table 28(Contd.): Percentage of the population of older age group (aged 65 and above) by country: 1950, 1980, 2015, and 2050 (Est.)
| Price : US$ 3500 |
Date : Nov 2024 |
| Category : Services |
Pages : 115 |
| Price : US$ 3500 |
Date : Nov 2024 |
| Category : Services |
Pages : 139 |
| Price : US$ 3500 |
Date : Nov 2024 |
| Category : Services |
Pages : 127 |
| Price : US$ 3500 |
Date : Nov 2024 |
| Category : Services |
Pages : 101 |
| Price : US$ 3500 |
Date : Nov 2024 |
| Category : Services |
Pages : 129 |
Request Sample 
Request Discount 
Inquire Before Buy
